ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 132 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $278 | -97.5% | 13 | -92.1% | 0.00% | – |
| Q1 2022 | $11,000 | -80.4% | 164 | -78.2% | 0.00% | -100.0% |
| Q4 2021 | $56,000 | +30.2% | 751 | -1.8% | 0.00% | 0.0% |
| Q3 2021 | $43,000 | +975.0% | 765 | +680.6% | 0.00% | – |
| Q2 2021 | $4,000 | +100.0% | 98 | +108.5% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 47 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | -60.0% | 47 | -53.0% | 0.00% | – |
| Q3 2020 | $5,000 | +400.0% | 100 | +185.7% | 0.00% | – |
| Q2 2020 | $1,000 | -96.4% | 35 | -89.9% | 0.00% | -100.0% |
| Q1 2018 | $28,000 | – | 348 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 858,811 | $36,156,000 | 10.56% |
| Fairmount Funds Management LLC | 150,433 | $6,333,000 | 2.26% |
| ARMISTICE CAPITAL, LLC | 1,356,000 | $57,088,000 | 1.94% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,775,000 | $74,728,000 | 0.45% |
| Virtus ETF Advisers LLC | 14,321 | $603,000 | 0.25% |
| Granahan Investment Management | 231,071 | $9,728,000 | 0.22% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 248,320 | $10,454,000 | 0.09% |
| ACADIAN ASSET MANAGEMENT LLC | 467,514 | $19,684,000 | 0.08% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 126 | $5,000 | 0.08% |
| AIGEN INVESTMENT MANAGEMENT, LP | 12,854 | $541,000 | 0.07% |